M.D. Anderson Cancer Center: all 3,044 studies

Page 12 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Anderson Circulating Tumor Cell Burden (CTCB) StudyTerminatedNCT00819832Phase 4Results posted
• Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)CompletedNCT00813124Phase 2Results posted
• Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's LymphomaTerminatedNCT00810576Phase 2Results posted
• Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic SyndromeCompletedNCT00806598Phase 2Results posted
• Busulfan and Fludarabine Followed by Post-transplant CyclophosphamideCompletedNCT00800839Phase 2Results posted
• Fludarabine, Cyclophosphamide, and Rituximab - High Dose FrontlineCompletedNCT00794820Phase 2Results posted
• A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing FatigueCompletedNCT00792077Phase 2Results posted
• Bendamustine in Acute Leukemia and MDSTerminatedNCT00790855Phase 1/2Results posted
• Aspirin Prophylaxis for Venous Thromboembolism in GlioblastomaTerminatedNCT00790452Phase 2Results posted
• Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial CancerActive, not recruitingNCT00788671Phase 2Results posted
• SAHA + CHOP in Untreated T-cell Non-Hodgkin's LymphomaCompletedNCT00787527Phase 1/2Results posted
• Personalized Treatment Selection for Metastatic Breast CancerTerminatedNCT00780676Phase 2Results posted
• Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)CompletedNCT00778375Phase 2Results posted
• Alemtuzumab + Rituximab Consolidation in CLLTerminatedNCT00771602Phase 2Results posted
• MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic CancerCompletedNCT00769483Phase 1/2Results posted
• Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation TherapyTerminatedNCT00766636Phase 2Results posted
• Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)CompletedNCT00759798Phase 2Results posted
• Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic LeukemiaCompletedNCT00759603Phase 2Results posted
• Phase II Neoadjuvant in Inflammatory Breast CancerTerminatedNCT00756470Phase 2Results posted
• Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)CompletedNCT00750737Phase 3Results posted
• Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial CancerCompletedNCT00749892Phase 2Results posted
• Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving IrinotecanCompletedNCT00748215Phase 2Results posted
• Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal CancerTerminatedNCT00745134Phase 2Results posted
• Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast CancerTerminatedNCT00739063Phase 2Results posted
• Relaxation and Heart Rate VariabilityCompletedNCT00735618Not applicableResults posted
• Methadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerTerminatedNCT00726830Not applicableResults posted
• Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus CancerTerminatedNCT00707473Phase 2Results posted
• Continuous Glucose Monitoring in Critically IllTerminatedNCT00707434Not applicableResults posted
• Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory NeuroblastomaTerminatedNCT00698009Phase 2Results posted
• Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin LymphomaCompletedNCT00695786Phase 2Results posted
• Lenalidomide (Revlimid) for the Treatment of Refractory Cancer PainTerminatedNCT00684242Phase 2Results posted
• Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)TerminatedNCT00675441Phase 2Results posted
• INCB018424 in Patients With Advanced Hematologic MalignanciesCompletedNCT00674479Phase 2Results posted
• Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient ChemotherapyTerminatedNCT00673179Not applicableResults posted
• Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic LeukemiaCompletedNCT00671658Phase 2Results posted
• Hysteroscopic Lymphatic Mapping for Endometrial CancerTerminatedNCT00671606Phase 2Results posted
• Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/LymphomaCompletedNCT00669877Phase 2Results posted
• A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using HypofractionationStatus unknownNCT00667888Phase 3Results posted
• Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma PatientsCompletedNCT00661544Phase 1/2Results posted
• Efficacy of the Third Eye Retroscope Auxiliary Imaging SystemCompletedNCT00657371Not applicableResults posted
• Inhaled Corticosteroids Versus Observation for Patients With Decreased Lung Function StatusTerminatedNCT00656916Phase 2Results posted
• Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)CompletedNCT00656617Phase 2Results posted
• A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDSCompletedNCT00656448Phase 3Results posted
• Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin LymphomaCompletedNCT00654732Phase 2Results posted
• Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom BurdenCompletedNCT00651937Phase 2Results posted
• Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma PatientsCompletedNCT00651755Not applicableResults posted
• Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic CancerTerminatedNCT00640978Phase 2Results posted
• Morphine Versus Methadone As First Line Strong Opioid for Cancer PainTerminatedNCT00634010Phase 3Results posted
• Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual DiseaseCompletedNCT00632359Phase 2Results posted
• Rasburicase in Patients at Risk for Tumor Lysis SyndromeCompletedNCT00628628Phase 2Results posted
• Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the CervixTerminatedNCT00626561Phase 2Results posted
• Multimodal Treatment Strategy for Cancer CachexiaTerminatedNCT00625742Not applicableResults posted
• Teriparatide (Forteo) in the Treatment of Patients With Postoperative HypocalcemiaTerminatedNCT00623974Phase 2Results posted
• Photopheresis for the Treatment of Acute Graft Versus Host DiseaseCompletedNCT00609609Phase 2Results posted
• Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine CarcinomaCompletedNCT00607113Phase 2Results posted
• Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell TransplantationCompletedNCT00591630Phase 2Results posted
• Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer PatientsTerminatedNCT00583622Phase 2Results posted
• Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma PatientsCompletedNCT00577993Phase 3Results posted
• Ph II Study of Azacitidine in MyelofibrosisCompletedNCT00569660Phase 2Results posted
• Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)CompletedNCT00569010Phase 1/2Results posted
• Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone MetastasisCompletedNCT00566618Phase 1/2Results posted
• TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00563784Phase 2Results posted
• Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell CarcinomaTerminatedNCT00561912Phase 2Results posted
• Role of Methadone As Co-Opioid AnalgesicTerminatedNCT00558870Phase 2Results posted
• Haelan and Nutrition in Cancer PatientsTerminatedNCT00558558Phase 2Results posted
• Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)TerminatedNCT00555399Phase 1/2Results posted
• Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For CancerCompletedNCT00553059Phase 3Results posted
• Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver DiseaseCompletedNCT00543777Phase 1/2Results posted
• Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)CompletedNCT00542971Phase 1/2Results posted
• Evaluate the Use of Paravertebral Block in Reconstructive Breast SurgeryCompletedNCT00542542Phase 3Results posted
• Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk NeuroblastomaTerminatedNCT00539500Phase 2/3Results posted
• OraTest in Combination With Visual Examination and Visual Examination AloneTerminatedNCT00537199Phase 3Results posted
• Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid MalignanciesCompletedNCT00536978Phase 2Results posted
• Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and OlderCompletedNCT00535873Phase 2Results posted
• Spectroscopy Versus Standard Care in Cervical Cancer PatientsTerminatedNCT00529464Phase 3Results posted
• Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung CancerTerminatedNCT00527982Phase 2Results posted
• Evaluation of the Bio-Seal Biopsy Track PlugCompletedNCT00527722Phase 2/3Results posted
• Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative TherapyCompletedNCT00526331Phase 4Results posted
• Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction PatientsCompletedNCT00526110Phase 1/2Results posted
• Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal CarcinomaCompletedNCT00525915Phase 2Results posted
• Non-Myeloablative Allogeneic Stem Cell TransplantationCompletedNCT00525876Not applicableResults posted
• Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)CompletedNCT00525785Phase 2Results posted
• CFAR Study in Patients With Chronic Lymphocytic LeukemiaCompletedNCT00525603Phase 2Results posted
• Dalteparin in Preventing DVT in Participants With CancerCompletedNCT00525057Not applicableResults posted
• Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma PatientsCompletedNCT00525031Phase 2Results posted
• Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid TumorTerminatedNCT00523809Phase 2Results posted
• Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDSCompletedNCT00520468Phase 2Results posted
• Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer PatientsTerminatedNCT00516269Phase 3Results posted
• Papillary Serous Carcinoma of the EndometriumCompletedNCT00515073Phase 2Results posted
• Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate CancerCompletedNCT00514540Phase 2Results posted
• Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer PatientsCompletedNCT00513357Phase 3Results posted
• Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the PenisCompletedNCT00512096Phase 2Results posted
• Gleevec Study for Patients With Ovarian CancerCompletedNCT00510653Phase 2Results posted
• Etanercept (Enbrel) for Juvenile Myelomonocytic LeukemiaTerminatedNCT00509600Phase 2Results posted
• Iressa Study in Patients With Salivary Gland CancerCompletedNCT00509002Phase 2Results posted
• Folfox-B Study for Patients With Colorectal Liver MetastasesTerminatedNCT00508872Phase 2Results posted
• Single Agent Alimta in Poor Performance Status in Non-small Cell Lung CancerCompletedNCT00508144Phase 2Results posted
• Pharmacogenetics, Emotional Reactivity and SmokingCompletedNCT00507728Phase 2/3Results posted
• Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)TerminatedNCT00506948Phase 2Results posted
• Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMTCompletedNCT00506922Phase 1/2Results posted

← M.D. Anderson Cancer Center overview and focus areas